NTRB
NTRB
NASDAQ · Pharmaceuticals

Nutriband Inc

$3.03
-0.11 (-3.50%)
As of Jun 25, 10:15 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.98M
Net Income
-8,013,959
Gross Margin
27.8%
Profit Margin
-404.1%
Rev Growth
-0.7%
D/E Ratio
0.02
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 27.8% 27.8% 54.8% 54.8%
Operating Margin -408.4% -367.6% 14.3% 15.1%
Profit Margin -404.1% -383.9% 12.0% 11.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.98M 2.00M 21.69M 16.36M
Gross Profit 551.7K 555.5K 11.89M 8.96M
Operating Income -8,101,437 -7,341,952 3.11M 2.47M
Net Income -8,013,959 -7,262,675 2.61M 1.89M
Gross Margin 27.8% 27.8% 54.8% 54.8%
Operating Margin -408.4% -367.6% 14.3% 15.1%
Profit Margin -404.1% -383.9% 12.0% 11.5%
Rev Growth -0.7% -0.7% +19.5% +23.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 424.9K 424.9K 24.66M 23.39M
Total Equity 17.20M 17.20M 37.36M 36.10M
D/E Ratio 0.02 0.02 0.66 0.65
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -7,910,809 -7,567,484 4.63M 3.66M
Free Cash Flow 2.95M 1.96M